Larvol Delta - A-Study-With-BPI1178-and-Osimertinib-in-Advanced-Nonsmall-Cell-Lung-Cancer-Patients-With-EGFR-Mutations

Tagrisso (osimertinib) - AstraZeneca

BPI-1178 - Beta Pharma

http://clinicaltrials.gov/ct2/show/NCT06362980

Apr 12, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next